Skip to main content

Advertisement

Log in

Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the impact of contrast-enhanced ultrasonography (CEUS) during percutaneous radiofrequency ablation (PRFA) procedure in renal cell carcinoma (RCC).

Methods

From January 2008 to July 2010, 73 patients with sporadic unilateral RCC were enrolled to our study (57 men and 16 women, age range: 37–78 years, mean age 57.9 years). The diameter of the tumor was 1.7–5.8, 3.4 cm on average. The patients were divided into two groups depending on the intraoperative ultrasonography type: CEUS group and conventional ultrasound group. Patients in CEUS group received CEUS before insertion of the electrode, and the second CEUS was performed right after the initial ablation to dynamically evaluate the images. If there was highly suspicious residue, additional ablation and repeated CEUS were applied. Patients in the conventional ultrasound group received PRFA guided by gray-scale ultrasound. All of these patients received contrast-enhanced computed tomography (CT) examination 7 days after the procedure (patients in CEUS group received CEUS conducted with each CT scan), with subsequent CT and CEUS assessment at 3, 6, and every 6 months thereafter.

Results

The mean follow-up period was 22 months (range: 12–42 months). All tumors were biopsied before RFA. The local tumor control rate was 94.6% (35/37) in the CEUS group and 86.1% (31/36) in the conventional ultrasound group (P < 0.05); the cancer-specific survival rate and the overall survival rate were 100%. The post-RFA (12 months) mean GFR levels were 84.7 ± 27.5 mL/min/1.73 m2 (P > 0.05, compared with pre-GFR: 86.4 ± 26.2 mL/min/1.73 m2) in the CEUS group and 81.9 ± 22.8 mL/min/1.73 m2 (P > 0.05, compared with pre-GFR: 83.5 ± 23.7 mL/min/1.73 m2) in the conventional ultrasound group.

Conclusion

Intraoperative CEUS can “real-time” monitor the ablated area during PRFA procedure. This technique can help to achieve a higher success rate compared with conventional ultrasound. No impact of intraoperative CEUS has been found on GFR level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Carraway WA, Raman JD, Cadeddu JA (2009) Current status of renal radiofrequency ablation. Curr Opin Urol 19:143–147

    Article  PubMed  Google Scholar 

  2. Boss A, Clasen S, Kuczyk M, et al. (2007) Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 17:725–733

    Article  PubMed  Google Scholar 

  3. Lyrdal D, Andersson M, Hellström M, et al. (2010) Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up. Acta Radiol 51:808–818

    Article  PubMed  Google Scholar 

  4. Solbiati L, Goldberg SN, Ierace T, et al. (1999) Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent–early experience. Radiology 211:643–649

    Article  CAS  PubMed  Google Scholar 

  5. Meloni MF, Bertolotto M, Alberzoni C, et al. (2008) Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol 191:1233–1238

    Article  PubMed  Google Scholar 

  6. Kong WT, Zhang WW, Guo HQ, et al. (2011) Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom Imaging 36:342–347

    Article  PubMed  Google Scholar 

  7. Hoeffel C, Pousset M, Timsit MO, et al. (2010) Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 20:1812–1821

    Article  PubMed  Google Scholar 

  8. Permpongkosol S, Link RE, Solomon SB, et al. (2006) Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings. J Urol 176:463–467

    Article  PubMed  Google Scholar 

  9. Farrell MA, Charboneau WJ, DiMarco DS, et al. (2003) Imaging-guided radiofrequency ablation of solid renal tumours. AJR Am J Roentgenol 180:1509–1513

    Article  CAS  PubMed  Google Scholar 

  10. Park S, Anderson JK, Matsumoto ED, et al. (2006) Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20:569–573

    Article  PubMed  Google Scholar 

  11. Lucas SM, Stern JM, Adibi M, et al. (2008) Renal function outcomes inpatients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179:75–79

    Article  PubMed  Google Scholar 

  12. Amersi FF, McElrath-Garza A, Ahmad A, et al. (2006) Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141:581–587

    Article  PubMed  Google Scholar 

  13. Soong M, Jupiter J, Rosenthal D (2006) Radiofrequency ablation of osteoid osteoma in the upper extremity. J Hand Surg Am 31:279–283

    Article  PubMed  Google Scholar 

  14. Susini T, Nori J, Olivieri S, et al. (2007) Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol 104:304–310

    Article  PubMed  Google Scholar 

  15. Zagoria RJ, Pettus JA, Rogers M, et al. (2011) Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77:1393–1397

    Article  PubMed  Google Scholar 

  16. Ferakis N, Bouropoulos C, Granitsas T, et al. (2010) Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J Endourol 24:1909–1913

    Article  PubMed  Google Scholar 

  17. Gervais DA, McGovern FJ, Arellano RS, et al. (2005) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185:64–71

    Article  PubMed  Google Scholar 

  18. Zagoria RJ, Traver MA, Werle DM, et al. (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436

    Article  PubMed  Google Scholar 

  19. Ji CW, Li XG, Zhang SW, et al. (2011) Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. Urology 77:798–802

    Article  PubMed  Google Scholar 

  20. Gupta A, Raman JD, Leveillee RJ, et al. (2009) General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol 23:1099–1105

    Article  PubMed  Google Scholar 

  21. Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613

    Article  CAS  PubMed  Google Scholar 

  22. Merkle EM, Nour SG, Lewin JS (2005) MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 235:1065–1071

    Article  PubMed  Google Scholar 

  23. Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 49:646–657

    Article  CAS  PubMed  Google Scholar 

  24. Bartolotta TV, Taibbi A, Midiri M, et al. (2008) Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging 33:501–511

    Article  PubMed  Google Scholar 

  25. Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35:750–756

    Article  PubMed  Google Scholar 

  26. Moschouris H, Stamatiou K, Kornezos I (2010) Re: Xu et al.: Renal cell carcinoma: real-time contrast-enhanced ultrasound finding. Abdom Imaging 35:507–509

    Article  CAS  PubMed  Google Scholar 

  27. Salvaggio G, Campisi A, Lo Greco V, et al. (2010) Evaluation of post treatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging 35:447–453

    Article  PubMed  Google Scholar 

  28. Zhu Q, Shimizu T, Endo H, et al. (2005) Assessment of renal cell carcinoma after cryoablation using contrast-enhanced gray-scale ultrasound: a case series. Clin Imaging 29:102–108

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongqian Guo.

Additional information

Xiaozhi Zhao and Wei Wang contribute equally to this work as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, X., Wang, W., Zhang, S. et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Radiol 37, 885–891 (2012). https://doi.org/10.1007/s00261-011-9828-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-011-9828-4

Keywords

Navigation